Ayral-Kaloustian; Semiramis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ayral-Kaloustian; Semiramis.The latest application filed is for "triazine compounds as pi3 kinase and mtor inhibitors".

Company Profile

0.28.44

Ayral-Kaloustian; Semiramis - Tarrytown NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 10,022,381 - Venkatesan , et al. July 17, 2	2018-07-17
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20170224696 - VENKATESAN; Aranapakam Mudumbai ; et al.	2017-08-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20170119778 - VENKATESAN; Aranapakam Mudumbai ; et al.	2017-05-04
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20150011752 - VENKATESAN; Aranapakam Mudumbai ; et al.	2015-01-08
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,859,542 - Venkatesan , et al. October 14, 2	2014-10-14
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20140248239 - VENKATESAN; Aranapakam Mudumbai ; et al.	2014-09-04
Triazine compounds as P13 kinase and MTOR inhibitors Grant 8,748,421 - Venkatesan , et al. June 10, 2	2014-06-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130315865 - VENKATESAN; Aranapakam Mudumbai ; et al.	2013-11-28
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,575,159 - Venkatesan , et al. November 5, 2	2013-11-05
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,445,486 - Venkatesan , et al. May 21, 2	2013-05-21
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130109670 - VENKATESAN; Aranapakam Mudumbai ; et al.	2013-05-02
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130005723 - Venkatesan; Aranapakam Mudumbai ; et al.	2013-01-03
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,217,036 - Venkatesan , et al. July 10, 2	2012-07-10
Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors Grant 8,129,371 - Zask , et al. March 6, 2	2012-03-06
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20110312955 - VENKATESAN; Aranapakam Mudumbai ; et al.	2011-12-22
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,039,469 - Venkatesan , et al. October 18, 2	2011-10-18
6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents Grant 7,915,266 - Zhang , et al. March 29, 2	2011-03-29
Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof Grant 7,713,994 - Tsou , et al. May 11, 2	2010-05-11
4-aryloxyquinolin-2(1h)-ones As Mtor Kinase And Pi3 Kinase Inhibitors, For Use As Anti-cancer Agents App 20100068204 - Tsou; Hwei-Ru ; et al.	2010-03-18
3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine And 3-substituted-1h-pyrrolo[3,2-b]pyridine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20100061982 - Ayral-Kaloustian; Semiramis ; et al.	2010-03-11
4-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine And N-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20100015141 - Bursavich; Matthew Gregory ; et al.	2010-01-21
(2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20100003250 - Chen; Zecheng ; et al.	2010-01-07
3-substituted-1h-indole Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20090311217 - Bursavich; Matthew Gregory ; et al.	2009-12-17
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20090304692 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-12-10
3-substituted-1h-pyrrolo[2,3-b]pyridine And 3-substituted-1h-pyrrolo[3,2-b]pyridine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20090298820 - Tsou; Hwei-Ru ; et al.	2009-12-03
Compounds for treating tumors Grant 7,626,023 - Zask , et al. December 1, 2	2009-12-01
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20090291079 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-11-26
2-Aryl-and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof App 20090270447 - Zhang; Nan ; et al.	2009-10-29
2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof App 20090270363 - Zhang; Nan ; et al.	2009-10-29
[a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES App 20090192147 - Ayral-Kaloustian; Semiramis ; et al.	2009-07-30
3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES App 20090181963 - Dehnhardt; Christoph Martin ; et al.	2009-07-16
PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS App 20090149458 - CHEN; Zecheng ; et al.	2009-06-11
5-arylpyrimidines as anticancer agents Grant 7,524,849 - Zhang , et al. April 28, 2	2009-04-28
Thienopyrimidine And Pyrazolopyrimidine Compounds And Their Use As Mtor Kinase And Pi3 Kinase Inhibitors App 20090098086 - Zask; Arie ; et al.	2009-04-16
6-[(substituted)phenyl]triazolopyrimidines as anticancer agents Grant 7,507,739 - Zhang , et al. March 24, 2	2009-03-24
Amino-substituted Quinazoline Derivatives As Inhibitors Of Beta-catenin/tcf-4 Pathway And Cancer Treatment Agents App 20090004185 - VENKATESAN; Aranapakam M. ; et al.	2009-01-01
6-Aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents App 20080255157 - Zhang; Nan ; et al.	2008-10-16
Wortmannin-rapamycin Conjugate And Uses Thereof App 20080249123 - GU; JIANXIN ; et al.	2008-10-09
Wortmannin-rapalog Conjugate And Uses Thereof App 20080249124 - GU; Jianxin ; et al.	2008-10-09
Imidazolopyrimidine Analogs And Their Use As Pi3 Kinase And Mtor Inhibitors App 20080233127 - Bursavich; Matthew Gregory ; et al.	2008-09-25
Pyrazolopyrimidine Analogs And Their Use As Mtor Kinase And Pi3 Kinase Inhibitors App 20080234262 - Zask; Arie ; et al.	2008-09-25
Compounds For Treating Tumors App 20080221181 - Zask; Arie ; et al.	2008-09-11
Process for the preparation of tubulin inhibitors Grant 7,396,835 - Wu , et al. July 8, 2	2008-07-08
Compounds for treating tumors Grant 7,390,910 - Zask , et al. June 24, 2	2008-06-24
Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof App 20080085890 - Tsou; Hwei-Ru ; et al.	2008-04-10
6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents Grant 7,285,555 - Zhang , et al. October 23, 2	2007-10-23
Hemiasterlin affinity probes and their uses App 20070026478 - Greenberger; Lee M. ; et al.	2007-02-01
3-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase Grant 6,949,661 - Epstein , et al. September 27, 2	2005-09-27
Process for the preparation of tubulin inhibitors App 20050124635 - Wu, Yanzhong ; et al.	2005-06-09
6-[(Substituted)phenyl]triazolopyrimidines as anticancer agents App 20050090508 - Zhang, Nan ; et al.	2005-04-28
5-arylpyrimidines as anticancer agents App 20050075357 - Zhang, Nan ; et al.	2005-04-07
6-Aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents App 20050065167 - Zhang, Nan ; et al.	2005-03-24
3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase Grant 6,861,445 - Epstein , et al. March 1, 2	2005-03-01
Compounds for treating tumors App 20050037977 - Zask, Arie ; et al.	2005-02-17
5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase Grant 6,784,184 - Epstein , et al. August 31, 2	2004-08-31
Method of treating resistant tumors App 20040121965 - Greenberger, Lee Martin ; et al.	2004-06-24
3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase Grant 6,740,675 - Epstein , et al. May 25, 2	2004-05-25
5-(Substituted)-5-(substitutedsulfonyl or sulfanyl) thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase Grant 6,716,862 - Salaski , et al. April 6, 2	2004-04-06
3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase App 20040063777 - Epstein, Joseph William ; et al.	2004-04-01
3-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase App 20040063971 - Epstein, Joseph William ; et al.	2004-04-01
5-Substituted-3(2H)-furanones useful for inhibition of farnesyl-protein transferase Grant 6,710,078 - Ayral-Kaloustian , et al. March 23, 2	2004-03-23
Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase Grant 6,605,628 - Ayral-Kaloustian , et al. August 12, 2	2003-08-12
5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-- diones useful for inhibition of farnesyl-protein transferase App 20030149063 - Epstein, Joseph William ; et al.	2003-08-07
Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase App 20030144301 - Ayral-Kaloustian, Semiramis ; et al.	2003-07-31
5-(Substituted)-5-(substitutedsulfonyl or sulfanyl) thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase App 20030096849 - Salaski, Edward James ; et al.	2003-05-22
3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrroldine-2,5-diones useful for inhibition of farnesyl-protein transferase App 20030083364 - Epstein, Joseph William ; et al.	2003-05-01
5-Substituted-3(2H)-furanones useful for inhibition of farnesyl-protein transferase App 20030073736 - Ayral-Kaloustian, Semiramis ; et al.	2003-04-17
Urethanes and ureas that induce cytokine production Grant 5,312,831 - Ayral-Kaloustian , et al. May 17, 1	1994-05-17
Antidiabetic phosphates Grant 4,968,790 - DeVries , et al. November 6, 1	1990-11-06
Antidiabetic phosphonates Grant 4,945,158 - DeVries , et al. July 31, 1	1990-07-31
Antidiabetic alpha-substituted phosphonates Grant 4,943,629 - DeVries , et al. July 24, 1	1990-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.